Generics of MSD diabetes pill set to flood market as patent expires - Economic Times

According to market research firm AIOCD, at least 50 Indian drug makers are jumping into the fray with around 100 generic versions of the popular anti-diabetes medication, leading to a likely price war.

The oral anti-diabetes drug market is in for a major shake-up as Merck, Sharp & Dohme's (MSD's) Januvia is expected to go off patent this month. According to market research firm AIOCD, at leas… [+998 chars]

full article...